Neoadjuvant Pertuzumab plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2 Positive Breast Cancer: Real-World Data from a National Institute of Oncology in Poland.
Preprint published in 2022 by
Agnieszka Irena Jagiełło-Gruszfeld,
Magdalena Rosinska,
Malgorzata Meluch,
Renata Sienkiewicz,
Anna Niwińska,
Katarzyna Pogoda 
,
Aleksander Grous,
Pawel Winter ,
Zbigniew I. Nowecki
,
Aleksander Grous,
Pawel Winter ,
Zbigniew I. Nowecki
